Tower Research Capital (TRC)’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,823
| Closed | -$665K | – | 5626 |
|
|
2020
Q3 | $665K | Sell |
7,823
-20,368
| -72% | -$1.03M | 0.01% | 1368 |
|
|
2020
Q2 | $999K | Buy |
+28,191
| New | +$824K | 0.04% | 531 |
|
|
2020
Q1 | – | Sell |
-13,195
| Closed | -$279K | – | 4363 |
|
|
2019
Q4 | $279K | Buy |
13,195
+8,227
| +166% | +$145K | 0.02% | 468 |
|
|
2019
Q3 | $66K | Buy |
4,968
+4,824
| +3,350% | +$70.9K | ﹤0.01% | 1607 |
|
|
2019
Q2 | $2K | Buy |
+144
| New | +$2.17K | ﹤0.01% | 3374 |
|
|
2019
Q1 | – | Sell |
-487
| Closed | -$7K | – | 4595 |
|
|
2018
Q4 | $7K | Buy |
487
+293
| +151% | +$5.82K | ﹤0.01% | 2746 |
|
|
2018
Q3 | $4K | Buy |
+194
| New | +$4.59K | ﹤0.01% | 3257 |
|
|
2018
Q2 | – | Sell |
-6,559
| Closed | -$96K | – | 4292 |
|
|
2018
Q1 | $96K | Buy |
6,559
+6,410
| +4,302% | +$105K | 0.01% | 1293 |
|
|
2017
Q4 | $2K | Sell |
149
-2,574
| -95% | -$30.4K | ﹤0.01% | 3278 |
|
|
2017
Q3 | $38K | Buy |
2,723
+1,948
| +251% | +$19.4K | ﹤0.01% | 2233 |
|
|
2017
Q2 | $7K | Buy |
+775
| New | +$5.44K | ﹤0.01% | 1849 |
|
|
2017
Q1 | – | Sell |
-142
| Closed | -$1K | – | 4264 |
|
|
2016
Q4 | $1K | Buy |
+142
| New | +$420 | ﹤0.01% | 3707 |
|
|
2016
Q2 | – | Sell |
-2,927
| Closed | -$7K | – | 5246 |
|
|
2016
Q1 | $7K | Sell |
2,927
-1,263
| -30% | -$2.84K | ﹤0.01% | 2443 |
|
|
2015
Q4 | $13K | Buy |
4,190
+3,516
| +522% | +$9.81K | ﹤0.01% | 1830 |
|
|
2015
Q3 | $1K | Sell |
674
-4,596
| -87% | -$11.7K | ﹤0.01% | 3742 |
|
|
2015
Q2 | $21K | Sell |
5,270
-4,850
| -48% | -$19.8K | ﹤0.01% | 2064 |
|
|
2015
Q1 | $39K | Buy |
+10,120
| New | +$44K | ﹤0.01% | 1684 |
|
|
2014
Q4 | – | Sell |
-141
| Closed | -$1K | – | 4975 |
|
|
2014
Q3 | $1K | Sell |
141
-227
| -62% | -$767 | ﹤0.01% | 4216 |
|
|
2014
Q2 | $1K | Sell |
368
-4,471
| -92% | -$16.4K | ﹤0.01% | 3822 |
|
|
2014
Q1 | $20K | Buy |
4,839
+2,987
| +161% | +$14.8K | ﹤0.01% | 1897 |
|
|
2013
Q4 | $9K | Sell |
1,852
-380
| -17% | -$1.69K | ﹤0.01% | 3122 |
|
|
2013
Q3 | $14K | Buy |
2,232
+232
| +12% | +$1.34K | ﹤0.01% | 2984 |
|
|
2013
Q2 | $11K | Buy |
+2,000
| New | +$6.57K | ﹤0.01% | 2320 |
|
Tower Research Capital (TRC)'s IMMU Position: Q4 2020 in Review
Tower Research Capital (TRC) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 7,823 shares — an estimated $665K sold.
Tower Research Capital (TRC) first reported a position in IMMU in Q2 2013 and held it in 23 quarters. The position peaked at $999K in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Tower Research Capital (TRC) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Tower Research Capital (TRC) sold 7,823 Immunomedics Inc shares in Q4 2020, an estimated $665K.
- Tower Research Capital (TRC) first reported a position in Immunomedics Inc in Q2 2013 and held it in 23 quarters.
- Tower Research Capital (TRC)'s Immunomedics Inc position peaked at $999K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.